Correlation Between Regenxbio and Coya Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Regenxbio and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenxbio and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regenxbio and Coya Therapeutics, Common, you can compare the effects of market volatilities on Regenxbio and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenxbio with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenxbio and Coya Therapeutics,.

Diversification Opportunities for Regenxbio and Coya Therapeutics,

-0.3

Correlation Coefficient

Regenxbio  Coya Therapeutics,

Very good diversification

The 3 months correlation between Regenxbio and Coya is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Regenxbio and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and Regenxbio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenxbio are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of Regenxbio i.e., Regenxbio and Coya Therapeutics, go up and down completely randomly.

Pair Corralation between Regenxbio and Coya Therapeutics,

Given the investment horizon of 90 days Regenxbio is expected to under-perform the Coya Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Regenxbio is 1.21 times less risky than Coya Therapeutics,. The stock trades about -0.03 of its potential returns per unit of risk. The Coya Therapeutics, Common is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  580.00  in Coya Therapeutics, Common on September 9, 2024 and sell it today you would earn a total of  32.00  from holding Coya Therapeutics, Common or generate 5.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Regenxbio  vs.  Coya Therapeutics, Common

Regenxbio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Regenxbio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Coya Therapeutics, Common

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Coya Therapeutics, Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Coya Therapeutics, sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Regenxbio and Coya Therapeutics,

The main advantage of trading using opposite Regenxbio and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenxbio position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.

The idea behind Regenxbio and Coya Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.